Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.

European journal of cancer (Oxford, England : 1990) - 1 Jul 2005

Wárlám-Rodenhuis Carla C, Koot Veronica C M, van der Luijt Rob B, Vasen Hans F A, Ausems Margreet G E M

Abstract excerpt

We prospectively screened a hospital-based population of 1000 successive breast cancer patients receiving adjuvant radiotherapy for predictive factors associated with the presence of BRCA1 and BRCA2 mutations. We offered genetic counseling and DNA analysis to selected patients. About 52% of patie...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Ovarian Neoplasms

Share to Predictive Value of Tests

Share to Prognosis

Share to Referral and Consultation

Source

Identifiers

PMID: 15955690
DOI: 10.1016/j.ejca.2005.02.030

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-15955690-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.PMID 15955690Read ↗

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil.Semantic proximity Read ↗

The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.Semantic proximity Read ↗

Screening and clinical implications for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.Semantic proximity Read ↗

Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.Semantic proximity Read ↗

Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.Semantic proximity Read ↗

BRCA1/2 mutations and triple negative breast cancers.Semantic proximity Read ↗

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.Semantic proximity Read ↗

Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.Semantic proximity Read ↗

Molecular and in silico analysis of BRCA1 and BRCA2 variants.Semantic proximity Read ↗

Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.